Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate the effect of mirtazapine augmentation in patients with sexual dysfunction induced by current selective serotonin reuptake inhibitor (SSRI) treatment. Methods: Forty‐nine outpatients in remission from major depressive disorder with SSRI treatment and experiencing treatment‐emergent sexual dysfunction were invited to participate and 33 (25 women and 8 men) were included in this 8‐week open‐label study. All patients continued her/his current SSRI treatment (dosages unchanged) and started on mirtazapine augmentation of 15 mg/day during the first week and 30 mg/day throughout the rest of the study. The Hamilton rating scale for depression (HAM‐D), the psychotropic‐related sexual dysfunction questionnaire (PRSexDQ), and the Golombok and Rust Inventory of Sexual Satisfaction (GRISS) were given to all patients at baseline and at each follow‐up (end of the first, second, fourth, sixth, and eight weeks). Results: Mirtazapine augmentation led to significant reductions in HAM‐D, PRSexDQ, and GRISS scores throughout the study especially after week 4 and 48.5% of patients (n = 16) reported that they had no overall sexual dysfunction at the end of the study. Conclusions: Mirtazapine augmentation is a good choice for the treatment of SSRI‐induced sexual dysfunction, and the results are typically seen later after 4–8 weeks. Copyright © 2008 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542 · cited 4×
“, 2002), 27–63% for sertraline (Clayton et al., 2002; Montejo et al., 2001), 30–73% for citalopram (Clayton et al.”
BackgroundInfluentialAntidepressant medications: a review of the evidence for drug-induced sexual dysfunction
Montgomery, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00313-5 · Cited by 205 · cited 2×
“, 2001) and varies by antidepressant (Montgomery et al., 2002).”
BackgroundAntidepressants and sexual dysfunction
Werneke, U., Northey, S., & Bhugra, D. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00890.x · Cited by 176
Bolling, M. Y., & Kohlenberg, R. J. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000080392 · Cited by 74
Cited by
Sexual Dysfunction, Depression, and the Impact of Antidepressants
Kennedy, S. H., & Rizvi, S. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819c76e9 · Cited by 338
Antidepressant‐induced sexual dysfunction
Rothmore, J. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50522 · Cited by 229
Strategies for managing sexual dysfunction induced by antidepressant medication
Taylor, M. J., Rudkin, L., Bullemor-Day, P., Lubin, J., Chukwujekwu, C., & Hawton, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003382.pub3 · Cited by 225
Neuroplasticity and the next wave of antidepressant strategies
Hayley, S., & Litteljohn, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00218 · Cited by 92
“For instance, Ozmenler et al. (2008) reported that mirtazapine augmentation in remitted depressed patients with SSRI treatment-emergent sexual dysfunction led to a significant reduction of depressive symptoms and, in nearly half the cases, completely ameliorated the SSRI-induced sexual problems.”
BackgroundA review of the adverse effects and safety of noradrenergic antidepressants
Whiskey, E., & Taylor, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113492027 · Cited by 64
“The addition of, or switching to, mirtazapine from serotonergic antidepressants is an acceptable strategy in managing antidepressant-induced sexual dysfunction (Gelenberg et al., 2000; Ozmenler et al., 2008; Ravindran et al., 2008) .”
Background
Metadata
- Authors
- Ozmenler, N. K., Karlidere, T., Bozkurt, A., Yetkin, S., Doruk, A., Sutcigil, L., Cansever, A., Uzun, O., Ozgen, F., & Ozsahin, A.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2008-02-15
- Volume
- 23
- Issue
- 4
- Pages
- 321-326
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2005537278
- Cited by
- 68
- References
- 4
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. https://app.cochat.ai/papers/10.1002/hup.929
- The paper
- Ozmenler, N. K., Karlidere, T., Bozkurt, A., Yetkin, S., Doruk, A., Sutcigil, L., Cansever, A., Uzun, O., Ozgen, F., & Ozsahin, A. (2008). Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.929
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.